Spots Global Cancer Trial Database for metformin xr
Every month we try and update this database with for metformin xr cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma | NCT04850846 | Monoclonal Gamm... Smoldering Mult... | Metformin XR Placebo | 18 Years - | Dana-Farber Cancer Institute | |
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both | NCT01999686 | Polycystic Ovar... Insulin Resista... | DLBS3233 Metformin XR Placebo metform... Placebo DLBS323... | 18 Years - 40 Years | Dexa Medica Group | |
Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma | NCT02967276 | Multiple Myelom... | Metformin XR Dexamethasone | 18 Years - | University of Campinas, Brazil | |
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma | NCT04850846 | Monoclonal Gamm... Smoldering Mult... | Metformin XR Placebo | 18 Years - | Dana-Farber Cancer Institute | |
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma | NCT04850846 | Monoclonal Gamm... Smoldering Mult... | Metformin XR Placebo | 18 Years - | Dana-Farber Cancer Institute | |
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both | NCT01999686 | Polycystic Ovar... Insulin Resista... | DLBS3233 Metformin XR Placebo metform... Placebo DLBS323... | 18 Years - 40 Years | Dexa Medica Group | |
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) | NCT01733459 | Polycystic Ovar... | DLBS3233 Metformin XR Placebo caplet ... Placebo capsule... | 18 Years - 40 Years | Dexa Medica Group | |
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | NCT04899349 | Breast Cancer | Alpelisib Fulvestrant Metformin XR Dapagliflozin +... Dapagliflozin | 18 Years - | Novartis | |
Treatment of Infertility in Women With Polycystic Ovary Syndrome | NCT00068861 | Polycystic Ovar... Infertility Pregnancy | metformin XR clomiphene citr... | 18 Years - 39 Years | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma | NCT04850846 | Monoclonal Gamm... Smoldering Mult... | Metformin XR Placebo | 18 Years - | Dana-Farber Cancer Institute | |
Treatment of Infertility in Women With Polycystic Ovary Syndrome | NCT00068861 | Polycystic Ovar... Infertility Pregnancy | metformin XR clomiphene citr... | 18 Years - 39 Years | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors | NCT02145559 | Breast Neoplasm... Lung Neoplasms Cancer of Liver Lymphoma Cancer of Kidne... | Metformin XR Delayed Metform... Sirolimus | 18 Years - | University of Chicago | |
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | NCT04899349 | Breast Cancer | Alpelisib Fulvestrant Metformin XR Dapagliflozin +... Dapagliflozin | 18 Years - | Novartis | |
Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis | NCT02022007 | Polycystic Ovar... Disorder of Glu... | Metformin XR Saxagliptin Saxagliptin-Met... | 18 Years - 42 Years | Woman's |